Jonathan Slonin insider trades
Open-market stock purchases and sales by Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc, from SEC Form 4 filings since Aug 3, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | PCRX Pacira BioSciences, Inc | Sold (not open market) | $106K |
| Mar 17, 2026 | PCRX Pacira BioSciences, Inc | Sold | $74.4K |
| Feb 11, 2026 | PCRX Pacira BioSciences, Inc | Bought (not open market) | — |
| Jan 30, 2026 | PCRX Pacira BioSciences, Inc | Sold (not open market) | $127K |
| Jan 2, 2026 | PCRX Pacira BioSciences, Inc | Sold (not open market) | $9.3K |
| Nov 17, 2025 | PCRX Pacira BioSciences, Inc | Sold | $95.4K |
Companies traded
- PCRX Pacira BioSciences, Inc: 12 sales, last Jun 3, 2026